Please use this identifier to cite or link to this item:
https://repository.iimb.ac.in/handle/2074/11531
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chatterjee, Chirantan | |
dc.contributor.author | Kubo, Kensuke | |
dc.contributor.author | Pingali, Viswanath | |
dc.date.accessioned | 2020-04-10T13:25:45Z | - |
dc.date.available | 2020-04-10T13:25:45Z | - |
dc.date.issued | 2013 | |
dc.identifier.issn | 0012-9976 | |
dc.identifier.uri | https://repository.iimb.ac.in/handle/2074/11531 | - |
dc.description.abstract | As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes in doctor behaviour, while pointing out potential issues with it. It argues that while the prices of older drugs might come down because of the new regulation, other issues pertaining to quality might arise. | |
dc.publisher | Economic and Political Weekly | |
dc.subject | Pharmaceutical industry | |
dc.subject | Health industry | |
dc.subject | Medicines | |
dc.subject | Crocin | |
dc.subject | Paracetamol | |
dc.title | Crocin or paracetamol: what should the doctor prescribe? | |
dc.type | Journal Article | |
dc.pages | 20-22p. | |
dc.vol.no | Vol.48 | - |
dc.issue.no | Iss.41 | - |
dc.journal.name | Economic and Political Weekly | |
Appears in Collections: | 2010-2019 |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.